Unexpected BNP levels in patients with advanced heart failure: A tale of caution and promise
Authors:
- Mark H. DraznerMDMark H. Drazner
- 1 February 2005
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 149 (2) , 187-189
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failureJACC, 2004
- Should B-Type Natriuretic Peptide Be Measured Routinely to Guide the Diagnosis and Management of Chronic Heart Failure?Circulation, 2003
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathyThe American Journal of Cardiology, 2002
- Medical Management of Advanced Heart FailureJAMA, 2002
- Nuggets, Pearls, and Vignettes of Master Heart Failure CliniciansCongestive Heart Failure, 2001
- Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): Design and rationaleAmerican Heart Journal, 2001
- High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failureJACC, 2000
- Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantationThe American Journal of Cardiology, 1989